![Monil Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Monil Shah
Corporate Officer/Principal presso
IMUGENE LIMITED
Patrimonio netto: 14 751 $ in data 31/05/2026
Profilo
Monil Shah was the founder of Ventrus Biosciences, Inc. (founded in 2011) where he held the title of Vice President-Clinical Research & Development from 2011 to 2014.
He is currently the Chief Business Officer at Imugene Ltd. (since 2021) and the Chief Development Officer at WindMIL Therapeutics, Inc. He previously served as the Chief Operating Officer at IRX Therapeutics, Inc. and Eterna Therapeutics LLC (from 2017 to 2018).
Dr. Shah also held the position of VP-Operations & Clinical Development at LTR Pharma Ltd. Dr. Shah obtained undergraduate and doctorate degrees from Rutgers State University of New Jersey.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IMUGENE LTD 0,04% | 30/06/2025 | 178.279 ( 0,04% ) | 14 751 $ | 31/05/2026 |
Posizioni attive di Monil Shah
| Società | Posizione | Inizio |
|---|---|---|
| IMUGENE LIMITED | Corporate Officer/Principal | 10/06/2021 |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Corporate Officer/Principal | - |
Precedenti posizioni note di Monil Shah
| Società | Posizione | Fine |
|---|---|---|
Eterna Therapeutics LLC
 Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Direttore operativo | 01/10/2018 |
Ventrus Biosciences, Inc.
 Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets phamaceutical products | Fondatore | 01/03/2014 |
IRX Therapeutics, Inc.
 IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Direttore operativo | - |
| LTR PHARMA LIMITED | Corporate Officer/Principal | - |
Formazione di Monil Shah
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
13
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Ventrus Biosciences, Inc.
Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets phamaceutical products | Health Technology |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Health Technology |
Eterna Therapeutics LLC
Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
Ltr Pharma Ltd.
 Ltr Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
